Literature DB >> 17666591

Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.

Isabel Uyttendaele1, Irma Lemmens, Annick Verhee, Anne-Sophie De Smet, Joël Vandekerckhove, Delphine Lavens, Frank Peelman, Jan Tavernier.   

Abstract

Binding of GH to its receptor induces rapid phosphorylation of conserved tyrosine motifs that function as recruitment sites for downstream signaling molecules. Using mammalian protein-protein interaction trap (MAPPIT), a mammalian two-hybrid method, we mapped the binding sites in the GH receptor for signal transducer and activator of transcription 5 (STAT5) a and b and for the negative regulators of cytokine signaling cytokine-inducible Src-homology 2 (SH2)-containing protein (CIS) and suppressor of cytokine signaling 2 (SOCS2). Y534, Y566, and Y627 are the major recruitment sites for STAT5. A non-overlapping recruitment pattern is observed for SOCS2 and CIS with positions Y487 and Y595 as major binding sites, ruling out SOCS-mediated inhibition of STAT5 activation by competition for shared binding sites. More detailed analysis revealed that CIS binding to the Y595, but not to the Y487 motif, depends on both its SH2 domain and the C-terminal part of its SOCS box, with a critical role for the CIS Y253 residue. This functional divergence of the two CIS/SOCS2 recruitment sites is also observed upon substitution of the Y+1 residue by leucine, turning the Y487, but not the Y595 motif into a functional STAT5 recruitment site.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666591     DOI: 10.1210/me.2006-0541

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Fos-Zippered GH Receptor Cytosolic Tails Act as Jak2 Substrates and Signal Transducers.

Authors:  Tobias Nespital; Lieke M van der Velden; Anneloes Mensinga; Elisabeth D van der Vaart; Ger J Strous
Journal:  Mol Endocrinol       Date:  2016-02-09

2.  Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways.

Authors:  Joris Wauman; Anne-Sophie De Smet; Dominiek Catteeuw; Denise Belsham; Jan Tavernier
Journal:  Mol Endocrinol       Date:  2007-12-28

3.  The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.

Authors:  Jeffrey J Babon; Jennifer K Sabo; Jian-Guo Zhang; Nicos A Nicola; Raymond S Norton
Journal:  J Mol Biol       Date:  2009-03-20       Impact factor: 5.469

4.  SIRT1 regulates adaptive response of the growth hormone--insulin-like growth factor-I axis under fasting conditions in liver.

Authors:  Masaaki Yamamoto; Genzo Iguchi; Hidenori Fukuoka; Kentaro Suda; Hironori Bando; Michiko Takahashi; Hitoshi Nishizawa; Susumu Seino; Yutaka Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 5.  Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.

Authors:  Lisa N Heppler; David A Frank
Journal:  Trends Cancer       Date:  2017-11-10

6.  Random mutagenesis MAPPIT analysis identifies binding sites for Vif and Gag in both cytidine deaminase domains of Apobec3G.

Authors:  Isabel Uyttendaele; Delphine Lavens; Dominiek Catteeuw; Irma Lemmens; Celia Bovijn; Jan Tavernier; Frank Peelman
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

7.  The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.

Authors:  Mattias Vesterlund; Fahad Zadjali; Torbjörn Persson; Michael Lund Nielsen; Benedikt M Kessler; Gunnar Norstedt; Amilcar Flores-Morales
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

8.  A dynamic view of domain-motif interactions.

Authors:  Eyal Akiva; Gilgi Friedlander; Zohar Itzhaki; Hanah Margalit
Journal:  PLoS Comput Biol       Date:  2012-01-12       Impact factor: 4.475

9.  Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.

Authors:  Douglas C Palmer; Geoffrey C Guittard; Zulmarie Franco; Joseph G Crompton; Robert L Eil; Shashank J Patel; Yun Ji; Nicholas Van Panhuys; Christopher A Klebanoff; Madhusudhanan Sukumar; David Clever; Anna Chichura; Rahul Roychoudhuri; Rajat Varma; Ena Wang; Luca Gattinoni; Francesco M Marincola; Lakshmi Balagopalan; Lawrence E Samelson; Nicholas P Restifo
Journal:  J Exp Med       Date:  2015-11-02       Impact factor: 14.307

10.  A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.

Authors:  Y Chhabra; H Y Wong; L F Nikolajsen; H Steinocher; A Papadopulos; K A Tunny; F A Meunier; A G Smith; B B Kragelund; A J Brooks; M J Waters
Journal:  Oncogene       Date:  2017-10-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.